Premium
Estrogen Therapy for the Lipid Abnormalities of Women on Dialysis
Author(s) -
Owen William,
Boston Elizabeth Ginsburg
Publication year - 1994
Publication title -
seminars in dialysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.899
H-Index - 78
eISSN - 1525-139X
pISSN - 0894-0959
DOI - 10.1111/j.1525-139x.1994.tb00826.x
Subject(s) - medicine , estrogen , dialysis , estrogen therapy , dialysis therapy , population , disease , lipoprotein , estrogen replacement therapy , endocrinology , intensive care medicine , cholesterol , environmental health
Cardiovascular disease is a major concern in dialysis patients, with many risk factors present in this population. An elevated lipoprotein (a) level is one such factor. Since estrogen levels are low in women on dialysis and estrogen therapy lowers lipoprotein (a) levels, wouldn't it be reasonable to treat most female dialysis patients with estrogens?